How to respond to NIH’s Specialized Disposable Gloves notice

What NIH is seeking

The National Institutes of Health Office of Logistics and Acquisition Operations is seeking information about the availability of U.S.-manufactured specialized disposable gloves for clinical, laboratory, animal-care, maintenance, and other hazardous work.

The notice describes sterile and non-sterile nitrile, neoprene, and polyisoprene gloves, including options such as extended cuffs, heavier thickness, cleanroom use, and documented resistance to chemicals or chemotherapy drugs. This is a sources-sought notice, not a contract opportunity or request for proposals.

Deadline and what it means

The notice was posted October 19, 2026. Responses are due November 3, 2026, at 1:00 p.m. Eastern Daylight Time.

The notice says responses are for market research. They are not offers and cannot be accepted as binding contracts. NIH is not obligated to issue a solicitation or award a contract, and it will not reimburse response-preparation costs.

Who this notice may suit

This opportunity may interest manufacturers and suppliers of specialized disposable gloves, especially firms able to describe U.S.-manufactured products in the glove types and use cases NIH identifies.

The notice lists NAICS code 315990, Apparel Accessories and Other Apparel Manufacturing, with a size standard of 500 employees, and Product Service Code 8415, Clothing, Special Purpose.

How to access the notice

Use “View original source” above to open the opportunity on the portal. If the first click opens the portal homepage, click it again to go to the bid.

A free account may be needed to view documents, though many bids do not require one.

Prepare a useful response

Organize your information by glove type and intended use. State whether each product is U.S.-manufactured and describe relevant material, thickness, cuff length, sterility, and other characteristics that match the notice.

Where available, include product-specific chemical resistance documentation for the material and thickness offered. The notice identifies permeation and degradation testing, and chemotherapy-drug resistance testing, as relevant evidence.

Keep claims specific and supported by product documentation. Since this is market research rather than a request for offers, make it easy for NIH to understand which products you can provide and how their documented characteristics relate to the uses described.